Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PRTH-101 |
Trade Name | |
Synonyms | PRTH101|PRTH 101 |
Drug Descriptions |
PRTH-101 is a humanized monoclonal antibody targeting DDR1, which potentially prevents immune exclusion in the tumor microenvironment and enhances antitumor response (PMID: 37328286). |
DrugClasses | DDR1 Inhibitor 10 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + PRTH-101 | PRTH-101 Pembrolizumab | 0 | 1 |
PRTH-101 | PRTH-101 | 0 | 1 |